Gentian Diagnostics ASA (OSL:GENT)
37.70
-1.30 (-3.33%)
Mar 9, 2026, 4:25 PM CET
Gentian Diagnostics ASA Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 105.93 | 84.74 | 87.64 | 81.6 | 114.94 | Upgrade
|
| Cash & Short-Term Investments | 105.93 | 84.74 | 87.64 | 81.6 | 114.94 | Upgrade
|
| Cash Growth | 25.01% | -3.31% | 7.41% | -29.00% | -27.25% | Upgrade
|
| Accounts Receivable | 13.8 | 23.29 | 11.57 | 10.06 | 6.51 | Upgrade
|
| Other Receivables | 10.47 | 7.98 | 5.41 | 9.13 | 16.07 | Upgrade
|
| Receivables | 24.27 | 31.28 | 16.98 | 19.19 | 22.58 | Upgrade
|
| Inventory | 54.14 | 45.94 | 37.12 | 38.54 | 29.78 | Upgrade
|
| Other Current Assets | - | -0 | - | 0 | - | Upgrade
|
| Total Current Assets | 184.34 | 161.96 | 141.73 | 139.33 | 167.3 | Upgrade
|
| Property, Plant & Equipment | 25.55 | 14.02 | 18.05 | 21.64 | 19.49 | Upgrade
|
| Other Intangible Assets | 35.83 | 28.46 | 21.16 | 26.82 | 25.01 | Upgrade
|
| Long-Term Deferred Tax Assets | 12.82 | 25.23 | - | - | - | Upgrade
|
| Other Long-Term Assets | - | - | 0.1 | 0 | 0 | Upgrade
|
| Total Assets | 258.54 | 229.66 | 181.04 | 187.79 | 211.79 | Upgrade
|
| Accounts Payable | 34.14 | 6.55 | 3.71 | 4.44 | 4.98 | Upgrade
|
| Accrued Expenses | - | 6.19 | 4.57 | 4.97 | 3.6 | Upgrade
|
| Current Portion of Leases | - | 4.53 | 4.04 | 3.7 | 4.11 | Upgrade
|
| Other Current Liabilities | - | 12.84 | 13 | 8.89 | 9.87 | Upgrade
|
| Total Current Liabilities | 34.14 | 30.11 | 25.32 | 22 | 22.55 | Upgrade
|
| Long-Term Leases | 19.44 | 5.51 | 9.01 | 11.62 | 14.47 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | 0.07 | - | - | Upgrade
|
| Other Long-Term Liabilities | - | -0 | - | - | - | Upgrade
|
| Total Liabilities | 53.58 | 35.61 | 34.4 | 33.62 | 37.02 | Upgrade
|
| Common Stock | 1.54 | 1.54 | 1.54 | 1.54 | 1.54 | Upgrade
|
| Additional Paid-In Capital | 318.03 | 314.72 | 312.14 | 309.1 | 305.75 | Upgrade
|
| Retained Earnings | -114.23 | -122.21 | -167.05 | -156.48 | -132.53 | Upgrade
|
| Comprehensive Income & Other | -0.38 | 0 | 0 | 0 | 0 | Upgrade
|
| Shareholders' Equity | 204.96 | 194.05 | 146.64 | 154.17 | 174.77 | Upgrade
|
| Total Liabilities & Equity | 258.54 | 229.66 | 181.04 | 187.79 | 211.79 | Upgrade
|
| Total Debt | 19.44 | 10.04 | 13.05 | 15.32 | 18.58 | Upgrade
|
| Net Cash (Debt) | 86.49 | 74.7 | 74.59 | 66.28 | 96.35 | Upgrade
|
| Net Cash Growth | 15.78% | 0.14% | 12.55% | -31.21% | -29.00% | Upgrade
|
| Net Cash Per Share | 5.58 | 4.74 | 4.84 | 4.30 | 6.25 | Upgrade
|
| Filing Date Shares Outstanding | 15.42 | 15.42 | 15.42 | 15.42 | 15.42 | Upgrade
|
| Total Common Shares Outstanding | 15.42 | 15.42 | 15.42 | 15.42 | 15.42 | Upgrade
|
| Working Capital | 150.2 | 131.85 | 116.41 | 117.34 | 144.74 | Upgrade
|
| Book Value Per Share | 13.29 | 12.58 | 9.51 | 10.00 | 11.33 | Upgrade
|
| Tangible Book Value | 169.12 | 165.59 | 125.48 | 127.35 | 149.76 | Upgrade
|
| Tangible Book Value Per Share | 10.97 | 10.74 | 8.14 | 8.26 | 9.71 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.